Advanced search
Publication Cover
Leukemia & Lymphoma Volume 43, 2002 - Issue 4
Submit an article Journal homepage
16
Views
3
CrossRef citations to date
0
Altmetric
Research Article

Prognostic Value of Bcl 10 Rearrangement in Diffuse Large B-cell Lymphoma

C. Kawasaki First Department of Pathology, School of Medicine, Fukuoka University, Nanakuma 7-45-1, Jyonanku, Fukuoka 814-0180, Japan
,
K. Ohshima First Department of Pathology, School of Medicine, Fukuoka University, Nanakuma 7-45-1, Jyonanku, Fukuoka 814-0180, Japan
,
H. Muta Department of Microbiology and Immunology, University of Miami, Miami, FL, USA
,
K. Muta The Third Department of Internal Medicine, Kyusyu University, Japan
,
V. Deyev Department of Microbiology and Immunology, University of Miami, Miami, FL, USA
,
E.R. Podack Department of Microbiology and Immunology, University of Miami, Miami, FL, USA
&
M. Kikuchi First Department of Pathology, School of Medicine, Fukuoka University, Nanakuma 7-45-1, Jyonanku, Fukuoka 814-0180, Japan
 show all
Pages 823-826 | Published online: 01 Jul 2009

  • Willis, T.G., Jadayel, D.M., Du, M.-Q., et al. (1999) "Bcl 10 is involved in t(1:14)(p22:q32) of MALT B-cell lymphoma and mutated in multiple tumor types", Cell 96, 35-45.
  • Takahashi, H., Hosokawa, Y., Suzuki, R., Morishima Y., Nakamura, S. and Seto, M. (1999) "Infrequent bcl 10 mutations in B-cell non-Hodgkin's lymphomas", Jpn J. Cancer Res. 90, 1316-1320.
  • Ohshima, K., Suzumiya, J., Salo, K., Kanda, M., Haraoka, S. and Kikuchi, K. (1999) "B-cell lymphoid of 708 cases in Japan: incidence rates and clinical prognosis according to REAL classification", Cancer Lett. 135, 73-81.
  • Harris, N.L., Jaffe, E.S., stein. H., et al. (1994) "A revised European American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group", Blood 84, 1361-1392.
  • Sanchez, K., Chacon, I., Plaza, M.M., et al. (1998) "Clinical outcome in diffuse large B-cell lymphoma is dependent on the relationship between different cell-cycle regulator proteins", J. Clin. Oncol. 16, 1931-1993.
  • Gascoyne, R.D., Adomat, S.A., Krajewski, S., et al. (1997) "Prognostic significance of bcl-2 protein expression and bcl-2 gene rearrangement in diffuse aggressive non-Hodgkin's lymphoma", Blood 90, 244-251.
  • Pins, M.A., Pezella, P., Martinez-Montero, J.C., et al. (1994) "p53 and bcl-2 expression in high-grade B-cell lymphomas: Correlation with survival time", Br. J. Cancer 69, 337-341.
  • Offit, K., Lo Coco, E. Louie, D.C., et al. (1994) "Rearrangement of bcl-6 gene as a prognostic marker in diffuse large-cell lymphoma", N. Engl. J. Med. 331, 74-80.
  • Wilson, W.H., Teruya-Feldestein, J., Fest, T., et al. (1997) "Relationship of p53, bcl-2, and tumor proliferation to clinical drug resistance in non Hodgkin's lymphomas", Blood 89, 601-609.
  • Kramer, M.H.H., Hermans, J., Parker, J., et al. (1996) "Clinical significance of bcl 2 and p53 protein expression in diffuse large B-cell lymphoma: a population-based study", J Clin. Oncol. 14, 2131-2138.
  • Miller, T.P., Grogan, T.M., Dahlberg, S., et al. (1994) "Prognostic significance of the Ki-67 associated proliferative antigen in aggressive non-Hodgkin's lymphomas: A prospective Southwest Oncology Group trial", Blood 83, 1460-1466.
  • Zhang, A., Ohshima, K., et al. (1999) "Prognostic clinicopathologic factors, including immunologic expression in diffuse large B-cell lymphomas", Pathol. Intern 49, 1043-1052.
  • Telford, E.A., Watson, M.S., Aird, H.C., Perry, J. and Davison, A.J. (1995) "The DNA sequence of equine herpesvirus 2", J. Mol. Biol. 249, 520-528.
  • Zou, H., Henzel, W.J., Liu, X., Lutschg, A. and Wang, X. (1997) "Apaf-1, a human protein homologous to C. elegans CED-4, participates in cytochromec-dependent activation of caspase-3", Cell 90, 405-413.
  • Seto, M., Yamamoto, K., Iida, S., et al. (1992) "Gene rearrangement and overexpression of PRAD1 in lymphoid malignancy with t(11:14)(q13;q32) translocation", Oncogene 7, 1401-1406.
  • Hsi, E.D., Eisbruch, A., Greenson, J.K., Singleton, T.P. Ross, C.W. and Schnitzer. B. [1998] "Classification of primary gastric lymphomas according to histologic features", Am. J. Surg Pathol. 22, 17-27.
  • Gaynor, E.R. and Fisher, R.I. (1990) "Diffuse aggressive lymphoma in adults", In: Magrach, I.T., ed. The Non-Hodgkin's Lymphomas (Williams and Wilkins, Baltimore), pp 317-329.
  • Zhang, Q. Siebert, R., Yan, M. et al. (1999) "Inactivating mutations and overexpivision of BCL 10, caspase recruitment domain-containing gene, in MALT lymphoma with t(1:14)(p22:q32)", Nat. Genet. 22, 63-68.
  • Koseki, T., Inohara, N., Chen, S., et at. (1999) "CIPER, a novel NF kappa B-activaling protein containing a caspase recruitment domain with homology to herpesvirus-2 proteinE10", J. Biol. Chem. 274, 9955-9961.
  • Yan, M., Lee, J., Schilbach, S., et al. (1999) "mE10, A novel caspase recruitment domain-containing proapoptotic molecule", J. Biol. Chem. 274, 10287-10292.
  • Yoneda, T., Imaizumi, K., Maeda, M., et al. (2000) "Regulatory mechanisms of TRAF2-mediated signal transduction by bcl 10, a MALT lymphoma-associated protein", J. Biol. Chem. 275, 1114-1120.
  • Yuille, M.R., Bradshaw, J.G.P.S. and Houlston, R.S. (1999) "BCL 10 in chronic lymphocytic leukaemia and T-cell prolymphocytic leukaemia", Br J. Haematol, 107, 384-385.
  • Kramer, M.H.H., Hermans, J., Wilburg, E., et al. (1998) "Clinical relevance of bcl2, bcl6, and myc rearrangements in diffuse large B-cell lymphoma", Blood 92, 3152-3162.
  • Vitolo, U., Gaidano, G., Botto, B., et al. (1998) "Rearrangements of bcl-6. bcl-2. c-myc and 6q deletion in B-diffuse large-cell lymphoma: clinical relevance in 71 patients", Ann. Oncol. 9, 55-61.
  • "The international non-Hodgkin's lymphoma prognostic factor project: a predictive model for aggressive non-Hodgkin's lymphoma", N. Engl. J. Med., 329 (1993) pp. 987-994.
  • Stone, J.G., Rowan, A.J., Tomlison, P.M., et al. (1999) "Mutations in bcl 10 are very rare in colorectal cancer", Br. J. Cancer 80, 1569-1570.
  • Lambers, A.R., Gumbs, C., Ali, S., et al. (1999) "Bcl 10 is not a target for frequent mutation in human carcinoma", Br. J. Cancer 80, 1575-1576.
  • van Schothorost, E.M., Mohkamsing, S., van Guip, R.J.H.L M., et al. (1999) "Lack of BCL 10 mutations in testicular germ cell tumors and derived cell lines", Br. J. Cancer 80, 1571-1574.
  • Ohshima, K., Muta, H., Kawasaki, C., et al. (2001) "Bcl 10 expression, rearrangement and mutation in MALT lymphoma: Correlation with expression of nuclear factor-?B", Int. J. Oncol. 19, 283-289.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.